(Q51889292)

17 April 2018

title

Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI. (English)

1 reference

17 April 2018

1 reference

1 reference

2

1 reference

17 April 2018

Kaj Blennow

6

object named as

Kaj Blennow

1 reference

17 April 2018

Arto Nordlund

1

1 reference

17 April 2018

Ola Klang

3

1 reference

17 April 2018

Karin Lind

4

1 reference

17 April 2018

Mona Pedersen

5

1 reference

17 April 2018

Ake Edman

7

1 reference

17 April 2018

Stefan Hansen

8

1 reference

17 April 2018

Anders Wallin

9

1 reference

17 April 2018

publication date

1 July 2008

1 reference

17 April 2018

Journal of the International Neuropsychological Society

published in

1 reference

17 April 2018

volume

14

1 reference

17 April 2018

issue

4

1 reference

17 April 2018

page(s)

582-590

1 reference

17 April 2018

Biomarker profiles and their relation to clinical variables in mild cognitive impairment.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Bedside assessment of executive cognitive impairment: the executive interview

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Mild cognitive impairment represents early-stage Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Mild cognitive impairment: directions for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Cerebrospinal fluid TAU protein and amyloid beta42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Neuropsychological markers of dementia in patients with memory complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Rehabilitation of executive dysfunction following brain injury: "content-free" cueing improves everyday prospective memory performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

APOE status and its association to learning and memory performance in middle aged and older Norwegians seeking assessment for memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

CSF biomarkers for mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Rates of progression in mild cognitive impairment and early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Disorders of visual and spatial perception in the early stage of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

ApoE: crossroads between Alzheimer's disease and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

Preclinical prediction of AD using neuropsychological tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

7 January 2021

Mild cognitive impairment: long-term course of four clinical subtypes

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

7 January 2021

Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

7 January 2021

Validation of the Warrington theory of visual processing and the Visual Object and Space Perception Battery.

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

7 January 2021

Classification criteria for mild cognitive impairment: a population-based validation study

1 reference

https://api.crossref.org/works/10.1017%2FS135561770808079X

7 January 2021

10.1017/S135561770808079X

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

18577287

1 reference

17 April 2018